Telephone sharing button Contact Us mailbox sharing button
arrow_left sharing button
arrow_right sharing button

Scientific Poster Download

Poster modified on 17/10/2023

An Integrated Approach to Accelerate the ADC Discovery, with Novel DAR Control and Developability Assessment Toolbox
Jiawei Lu, Qirui Fan, Jun Wang, Sudhir Patil, Wei Gu, George Wang, Lily Yin, and Jimmy Li

Scientists constantly experience a lot of challenges during years of discovery process, such as fragmented CRO network, challenging conjugation, and analytical characterization for diversified moieties. Among those faced during discovery efforts for antibody-drug conjugates (ADCs), is the precise control of drug-to-antibody ratio (DAR) and drug distribution. WuXi XDC’s integrated bioconjugate discovery platform, WuXi DAR technology, includes antibody, linker-payload and ADC/bioconjugate preparation, developability assessment, proprietary narrow DAR distribution technology, and in vitro/in vivo characterization to precisely control the conjugate drug load to DAR2, DAR4 or DAR6.


This scientific poster was originally presented during the 2023 World ADC Conference in London

Discuss This Poster

To discuss the data in this poster, please complete the form on the following page to connect with our experts.

Connect with our Experts


You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?